EHI
UTHR icon

Eagle Health Investments’s United Therapeutics UTHR Stock Holding History

Eagle Health Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,000
Closed -$8.36M – 31
2021
Q1 		$8.36M Buy
+50,000
New +$8.34M 3.28% 13

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Eagle Health Investments's UTHR Position: Q1 2025 in Review

Eagle Health Investments sold out of United Therapeutics (UTHR) in Q1 2025, closing a stake of 21,802 shares — an estimated $7.69M sold.

Eagle Health Investments first reported a position in UTHR in Q4 2020 and held it in 17 quarters. The position peaked at $53.4M in Q2 2024. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Eagle Health Investments reported no remaining United Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Eagle Health Investments sold 21,802 United Therapeutics shares in Q1 2025, an estimated $7.69M.
  • Eagle Health Investments first reported a position in United Therapeutics in Q4 2020 and held it in 17 quarters.
  • Eagle Health Investments's United Therapeutics position peaked at $53.4M in Q2 2024.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Eagle Health Investments's 13F filing for Q1 2025, filed 12 May 2025.